Budget Impact Analysis Of Wider Adoption Of Biphasic Insulin Aspart (Biasp) In The Treatment Of Type 2 Diabetes Mellitus (T2dm)- A Perspective Of Patients Treated By Public Providers In Singapore
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.153
https://www.valueinhealthjournal.com/article/S1098-3015(14)02083-X/fulltext
Title :
Budget Impact Analysis Of Wider Adoption Of Biphasic Insulin Aspart (Biasp) In The Treatment Of Type 2 Diabetes Mellitus (T2dm)- A Perspective Of Patients Treated By Public Providers In Singapore
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)02083-X&doi=10.1016/j.jval.2014.08.153
First page :
A743
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
2158